EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, data and analytics, research and life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions, such as bespoke websites for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom.
U.K. Market Performance
7D7 Days: 1.1%
3M3 Months: 7.3%
1Y1 Year: 7.4%
YTDYear to Date: 7.7%
Over the last 7 days, the market has remained flat, although notably the Healthcare sector declined by 3.7%. Meanwhile, the market is actually up 6.7% over the past year. Earnings are forecast to grow by 15% annually. Market details ›
The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.